Loss of IDO1 expression from human pancreatic B-cells precedes their destruction during the development of type 1 diabetes

Diabetes

Volumn 67, Issue 9, 2018, Pages 1858-1866

  Anquetil, Florence ^b   Mondanelli, Giada ^c   Gonzalez, Nathaly ^b   Calvo, Teresa Rodriguez ^b   Gonzalo, Jose Zapardiel ^b   Krogvold, Lars ^d,e   Dahl Jørgensen, Knut ^d   Van Den Eynde, Benoit ^a,f   Orabona, Ciriana ^c   Grohmann, Ursula ^c   Von Herrath, Matthias G ^b,g  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^c UNIVERSITY OF PERUGIA   (Italy)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF OSLO   (Norway)

^f DE DUVE INSTITUTE   (Belgium)

^g NOVO NORDISK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; HUMAN INSULIN; INDOLEAMINE 2,3 DIOXYGENASE; INDOLEAMINE 2,3 DIOXYGENASE 1; INSULIN; INSULIN GLARGINE; INSULIN LISPRO; UNCLASSIFIED DRUG; INDOLEAMINE 2,3-DIOXYGENASE 1, HUMAN;

ADOLESCENT; ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MIDDLE AGED; PANCREAS ISLET BETA CELL; PANCREAS TISSUE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; YOUNG ADULT; AGED; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CADAVER; COHORT ANALYSIS; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DISEASE EXACERBATION; DOWN REGULATION; ENZYMOLOGY; IMMUNOLOGY; IMPAIRED GLUCOSE TOLERANCE; INDIRECT FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; PATHOPHYSIOLOGY; PROTEIN TRANSPORT;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CADAVER; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; DOWN-REGULATION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INSULIN; INSULIN-SECRETING CELLS; MALE; MIDDLE AGED; PREDIABETIC STATE; PROTEIN TRANSPORT; YOUNG ADULT;

EID: 85052715262     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db17-1281     Document Type: Conference Paper

References (25)

1. Yeung AW, Terentis AC, King NJ, Thomas SR. Role of indoleamine 2,3-dioxygenase in health and disease. Clin Sci (Lond) 2015;129:601-672
2. Mellor AL, Munn DH. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 2004;4:762-774
3. Fallarino F, Grohmann U, You S, et al. The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells. J Immunol 2006;176:6752-6761
4. Munn DH. Indoleamine 2,3-dioxygenase, tumor-induced tolerance and counter-regulation. Curr Opin Immunol 2006;18:220-225
5. Grohmann U, Fallarino F, Bianchi R, et al. A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice. J Exp Med 2003;198:153-160
6. Saxena V, Ondr JK, Magnusen AF, Munn DH, Katz JD. The countervailing actions of myeloid and plasmacytoid dendritic cells control autoimmune diabetes in the nonobese diabetic mouse. J Immunol 2007;179:5041-5053
7. Ueno A, Cho S, Cheng L, et al. Transient upregulation of indoleamine 2,3-dioxygenase in dendritic cells by human chorionic gonadotropin down-regulates autoimmune diabetes. Diabetes 2007;56:1686-1693
8. Orabona C, Mondanelli G, Pallotta MT, et al. Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1in juvenile diabetes. JCI Insight 2018;3: e96244
9. Krogvold L, Edwin B, Buanes T, et al. Pancreatic biopsy by minimal tail resection in live adult patients at the onset of type 1 diabetes: experiences from the DiViD study. Diabetologia 2014;57:841-843
10. Campbell-Thompson ML, Montgomery EL, Foss RM, et al. Collection protocol for human pancreas. J Vis Exp 2012;63:e4039
11. Théate I, van Baren N, Pilotte L, et al. Extensive profiling of the expression of the indoleamine 2,3-dioxygenase 1 protein in normal and tumoral human tissues. Cancer Immunol Res 2015;3:161-172
12. Meier DT, Entrup L, Templin AT, et al. Determination of optimal sample size for quantification of b-cell area, amyloid area and b-cell apoptosis in isolated islets. J Histochem Cytochem 2015;63:663-673
13. Anquetil F, Sabouri S, Thivolet C, et al. Alpha cells, the main source of IL-1b in human pancreas. J Autoimmun 2017;81:68-73
14. Baban B, Penberthy WT, Mozaffari MS. The potential role of indoleamine 2,3 dioxygenase (IDO) as a predictive and therapeutic target for diabetes treatment: a mythical truth. EPMA J 2010;1:46-55
15. Pallotta MT, Orabona C, Volpi C, et al. Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells. Nat Immunol 2011;12: 870-878
16. Munn DH, Mellor AL. Indoleamine 2,3 dioxygenase and metabolic control of immune responses. Trends Immunol 2013;34:137-143
17. Liu JJ, Raynal S, Bailbé D, et al. Expression of the kynurenine pathway enzymes in the pancreatic islet cells. Activation by cytokines and glucolipotoxicity. Biochim Biophys Acta 2015;1852:980-991
18. Sarkar SA, Wong R, Hackl SI, et al. Induction of indoleamine 2,3-dioxygenase by interferon-gamma in human islets. Diabetes 2007;56:72-79
19. Fallarino F, Gizzi S, Mosci P, Grohmann U, Puccetti P. Tryptophan catabolism in IDO+ plasmacytoid dendritic cells. Curr Drug Metab 2007;8:209-216
20. Ahmad S, Tabassum S, Haider S. Role of decreased plasma tryptophan in memory deficits observed in type-I diabetes. J Pak Med Assoc 2013;63:65-68
21. Oxenkrug G, van der Hart M, Summergrad P. Elevated anthranilic acid plasma concentrations in type 1 but not type 2 diabetes mellitus. Integr Mol Med 2015;2:365-368
22. Zhang Y, Jalili RB, Kilani RT, et al. IDO-expressing fibroblasts protect islet beta cells from immunological attack and reverse hyperglycemia in non-obese diabetic mice. J Cell Physiol 2016;231:1964-1973
23. Mondanelli G, Albini E, Pallotta MT, et al. The proteasome inhibitor bortezomib controls indoleamine 2,3-dioxygenase 1 breakdown and restores immune regulation in autoimmune diabetes. Front Immunol 2017; 8:428
24. Song P, Ramprasath T, Wang H, Zou MH. Abnormal kynurenine pathway of tryptophan catabolism in cardiovascular diseases. Cell Mol Life Sci 2017;74: 2899-2916
25. Mondanelli G, Ugel S, Grohmann U, Bronte V. The immune regulation in cancer by the amino acid metabolizing enzymes ARG and IDO. Curr Opin Pharmacol 2017;35:30-39